doi: 10.1016/j.prp.2023.154538 514 KaushikMTikuA
Researchers observed notable increases of nearly 198% in 3-HB and 95% in the C2/C0 ratio at the 12 mg dose in these participants
hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
Recent project sample photos: Please click or tap on screen to see full image Shooting skincare product photos for ecommerce requires attention to detail to showcase the product effectively and attract potential customers
These challenges arise mainly from CSC heterogeneity and plasticity, the lack of reliable biomarkers, and the complex interactions between CSCs and the TME